Bei Zhu

1.8k total citations
61 papers, 1.4k citations indexed

About

Bei Zhu is a scholar working on Molecular Biology, Nephrology and Cancer Research. According to data from OpenAlex, Bei Zhu has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Nephrology and 13 papers in Cancer Research. Recurrent topics in Bei Zhu's work include Chronic Kidney Disease and Diabetes (13 papers), Dialysis and Renal Disease Management (10 papers) and RNA modifications and cancer (8 papers). Bei Zhu is often cited by papers focused on Chronic Kidney Disease and Diabetes (13 papers), Dialysis and Renal Disease Management (10 papers) and RNA modifications and cancer (8 papers). Bei Zhu collaborates with scholars based in China, United States and Croatia. Bei Zhu's co-authors include Weihong Zhao, Xiaohua Pei, Jin Bo Tang, Juan He, Jianqing Wu, Cuiyu Wang, Jianqing Wu, Yi Cao, Renguo Xie and Xiao Tian Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Bone and Joint Surgery.

In The Last Decade

Bei Zhu

59 papers receiving 1.4k citations

Peers

Bei Zhu

SURGE

NEPHR

EPIDE

Lie Dai China

Zafar A. Shah India

Rafael Velázquez‐Cruz Mexico

Zongwen Shuai China

P. F. J. Ryan Australia

Wenfeng Tan China

Mihir D. Wechalekar Australia

Fabian Benz Germany

Min Gu China

Masayoshi Okumi Japan

Lie Dai China

Bei Zhu

393 ×0.6

138 ×0.4

174 ×0.5

SURGE

171 ×0.6

NEPHR

251 ×1.4

EPIDE

Citations per year, relative to Bei Zhu Bei Zhu (= 1×) peers Lie Dai

Countries citing papers authored by Bei Zhu

Since Specialization

Citations

This map shows the geographic impact of Bei Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei Zhu more than expected).

Fields of papers citing papers by Bei Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bei Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei Zhu. The network helps show where Bei Zhu may publish in the future.

Co-authorship network of co-authors of Bei Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Bei Zhu. A scholar is included among the top collaborators of Bei Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bei Zhu. Bei Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Bei, et al.. (2025). Intelligent Monitoring of Tunnel Fire Smoke Based on Improved YOLOX and Edge Computing. Applied Sciences. 15(4). 2127–2127. 3 indexed citations

Yang, Su‐Jin, et al.. (2024). Exosome-delivered microRNAs confer adriamycin-resistance through modulating the immune and metabolism-related gene PTEN in HER2-negative breast cancer.. Journal of Clinical Oncology. 42(16_suppl). e12500–e12500. 1 indexed citations

Lu, Wei, Yao Ma, Bei Zhu, et al.. (2024). Multiple and large simple renal cysts are associated with glomerular filtration rate decline: a cross-sectional study of Chinese population. European journal of medical research. 29(1). 11–11. 3 indexed citations

Zhou, Sufeng, Lijun Xie, Yuqing Zhao, et al.. (2023). Safety, Pharmacokinetics, and Pharmacodynamics of Midazolam Gel After Rectal Administration in Healthy Chinese Subjects. Clinical Drug Investigation. 43(6). 421–433. 1 indexed citations

Zhou, Sufeng, Lijun Xie, Juan Chen, et al.. (2023). Keverprazan, a novel potassium‐competitive acid blocker: Multiple oral doses safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects. Clinical and Translational Science. 16(10). 1911–1922. 13 indexed citations

Wu, Jiahao, et al.. (2023). Identification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer. Journal of Cancer Research and Clinical Oncology. 149(18). 16779–16795. 4 indexed citations

Wu, Jiahao, et al.. (2023). Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer. Scientific Reports. 13(1). 18390–18390. 17 indexed citations

Zhou, Sufeng, Lijun Xie, Yuqing Zhao, et al.. (2023). Keverprazan, a novel potassium-competitive acid blocker: Single ascending dose safety, tolerability, pharmacokinetics, pharmacodynamics and food effect in healthy subjects. European Journal of Pharmaceutical Sciences. 190. 106578–106578. 12 indexed citations

Lu, Wei, et al.. (2022). Thyroid function and age-related decline in kidney function in older Chinese adults: a cross-sectional study. BMC Geriatrics. 22(1). 221–221. 4 indexed citations

10.

Zhu, Bei, et al.. (2020). Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis. Bioscience Reports. 40(2). 37 indexed citations

11.

Zhu, Bei, Wei‐xian Chen, Yue Fu, et al.. (2020). <p>MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2 and Activating PI3K/Akt Pathway in Breast Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 6873–6884. 12 indexed citations

12.

Pei, Xiaohua, et al.. (2018). Mild cognitive impairment in maintenance hemodialysis patients: a cross-sectional survey and cohort study. Clinical Interventions in Aging. Volume 14. 27–32. 16 indexed citations

13.

Li, Qian, Xiyu Zhang, Tianqi Dong, et al.. (2018). Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Cellular Physiology and Biochemistry. 50(3). 987–1004. 36 indexed citations

14.

Li, Hongliang, Shuxian Chen, Jia Liu, et al.. (2017). Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer. Biochemical and Biophysical Research Communications. 495(3). 2350–2355. 58 indexed citations

15.

Fen, LI, Xiaohua Pei, Xun Liu, et al.. (2016). Modification of the 2012 CKD-EPI equations for the elderly Chinese. International Urology and Nephrology. 49(3). 467–473. 3 indexed citations

16.

Zhu, Bei, Cuiyu Wang, Xiaoli Zhang, et al.. (2015). Relationships between interleukin-12B and interleukin-10 gene polymorphisms and hepatitis C in Chinese Han hemodialysis patients. Renal Failure. 37(3). 505–510. 5 indexed citations

17.

Zhu, Ying, Bei Zhu, Xiaohua Pei, et al.. (2014). Comparisons between the 2012 New CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) Equations and Other Four Approved Equations. PLoS ONE. 9(1). e84688–e84688. 40 indexed citations

18.

Zhu, Bei, et al.. (2012). Effects of Coupled Plasma Filtration Adsorption on Septic Patients with Multiple Organ Dysfunction Syndrome. Renal Failure. 34(7). 834–839. 25 indexed citations

19.

Wang, Cuiyu, Jinghua Sun, Bei Zhu, et al.. (2010). Hepatitis B virus infection and related factors in hemodialysis patients in China – systematic review and meta-analysis. Renal Failure. 32(10). 1255–1264. 59 indexed citations

20.

Tang, Jin Bo, Yi Cao, Bei Zhu, et al.. (2008). Adeno-Associated Virus-2-Mediated bFGF Gene Transfer to Digital Flexor Tendons Significantly Increases Healing Strength. Journal of Bone and Joint Surgery. 90(5). 1078–1089. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact